Real-World Patent Foramen Ovale (PFO) Closure in Japan ― 30-Day Clinical Outcomes from the Amplatzer<sup>TM</sup> PFO Occluder Japan Post-Marketing Surveillance Study ―

Teiji Akagi,Hidehiko Hara,Hideaki Kanazawa,Shigefumi Fukui,Yoichiro Hashimoto,Yasuyuki Iguchi,Toru Iwama,Hiroharu Kataoka,Akio Kawamura,Hiroyuki Kawano,Koichi Oki,Hiroshi Yamagami

Circulation Journal（2024）

引用 0|浏览15

暂无评分

摘要

Background: The AmplatzerTM PFO Occluder was approved for marketing in Japan in May 2019, and the Amplatzer PFO Occluder Japan Post-marketing Surveillance (PFO Japan PMS) study was initiated in December 2019. This analysis presents 30-day clinical outcomes for PFO Japan PMS study patients.

查看译文

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要

Real-World Patent Foramen Ovale (PFO) Closure in Japan ― 30-Day Clinical Outcomes from the Amplatzer&lt;sup&gt;TM&lt;/sup&gt; PFO Occluder Japan Post-Marketing Surveillance Study ―

Real-World Patent Foramen Ovale (PFO) Closure in Japan ― 30-Day Clinical Outcomes from the Amplatzer<sup>TM</sup> PFO Occluder Japan Post-Marketing Surveillance Study ―